An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles

References

• Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: facts, myths, evidence and controversies. Indian J Dermatol Venereol Leprol. 2016;82(3):262–272.
   PubMed Web of Science ®Google Scholar
• Hashemi SM, Emami S. Kojic acid-derived tyrosinase inhibitors: synthesis and bioactivity. Pharm Biomed Res. 2015;1(1):1–17.
   Google Scholar
• Noh J-M, Kwak S-Y, Kim D-H, et al. Kojic acid-tripeptide amide as a new tyrosinase inhibitor. Biopolymers. 2007;88(2):300–307.
   PubMed Web of Science ®Google Scholar
• Silpa-Archa N, Kohli I, Chaowattanapanit S, et al. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591–605.
   PubMed Web of Science ®Google Scholar
• James WD, Elston D, Berger T. Andrew’s diseases of the skin e-book: clinical dermatology-expert consult-online and print. Philadelphia: Elsevier Health Sciences, 2011.
   Google Scholar
• Duarte I, Campos Lage AC. Frequency of dermatoses associated with cosmetics. Contact Derm. 2007;56(4):211–213.
   PubMed Web of Science ®Google Scholar
• Nicolaidou E, Katsambas AD. Pigmentation disorders: hyperpigmentation and hypopigmentation. Clin Dermatol. 2014;32(1):66–72.
   PubMed Web of Science ®Google Scholar
• Lim JTE. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatologic surgery. 1999;25(4):282–284.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol. 2009;54(4):303–309.
   PubMed Web of Science ®Google Scholar
• Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019;110:582–593.
   PubMed Web of Science ®Google Scholar
• Burnett CL, Bergfeld WF, Belsito DV, et al. Final report of the safety assessment of kojic acid as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):244S–22473S.
   PubMed Web of Science ®Google Scholar
• Serra-Baldrich E, Tribó MJ, Camarasa JG. Allergic contact dermatitis from kojic acid. Contact Derm. 1998;39(2):86–87.
   PubMed Web of Science ®Google Scholar
• García-Gavín J. Pigmented contact dermatitis due to kojic acid. A paradoxical side effect of a skin lightener. Contact Dermatitis. 2010;62(1):63–64.
   PubMed Web of Science ®Google Scholar
• Fattal E, Bochot A. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm. 2008;364(2):237–248.
   PubMed Web of Science ®Google Scholar
• Ishihara T, Mizushima T. Techniques for efficient entrapment of pharmaceuticals in biodegradable solid micro/nanoparticles. Expert Opin Drug Deliv. 2010;7(5):565–575.
   PubMed Web of Science ®Google Scholar
• Vrignaud S, Benoit J-P, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32(33):8593–8604.
   PubMed Web of Science ®Google Scholar
• Khezri K, Saeedi M, Dizaj SM. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations. Biomed Pharmacother. 2018;106:1499–1505.
   PubMed Web of Science ®Google Scholar
• Mishra DK, Dhote V, Bhatnagar P, et al. Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research. Drug Deliv Transl Res. 2012;2(4):238–253.
   PubMed Web of Science ®Google Scholar
• Geszke-Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C Mater Biol Appl. 2016;68:982–994.
   PubMed Web of Science ®Google Scholar
• Wang Y-W, Jou C-H, Hung C-C, et al. Cellular fusion and whitening effect of a chitosan derivative coated liposome. Colloids Surf B Biointerfaces. 2012;90:169–176.
   PubMed Web of Science ®Google Scholar
• Hussein-Al-Ali SH, El Zowalaty ME, Hussein MZ, et al. Novel kojic acid-polymer-based magnetic nanocomposites for medical applications. Int J Nanomedicine. 2014;9:351–362.
   PubMed Web of Science ®Google Scholar
• Ghanbarzadeh S, Hariri R, Kouhsoltani M, et al. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;136:1004–1010.
   PubMed Web of Science ®Google Scholar
• Liu J-J, Nazzal S, Chang T-S, et al. Preparation and characterization of cosmeceutical liposomes loaded with avobenzone and arbutin. J Cosmet Sci. 2013;64(1):9–17.
   PubMed Web of Science ®Google Scholar
• Duarah S, Durai RD, Narayanan VB. Nanoparticle-in-gel system for delivery of vitamin C for topical application. Drug Deliv Transl Res. 2017;7(5):750–760.
   PubMed Web of Science ®Google Scholar
• Mosallaei N, Mahmoudi A, Ghandehari H, et al. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): preparation, characterization, in vitro, and in vivo evaluations. Eur J Pharm Biopharm. 2016;104:42–50.
   PubMed Web of Science ®Google Scholar
• Akbari J, Saeedi M, Morteza-Semnani K, et al. The design of naproxen solid lipid nanoparticles to target skin layers. Colloids Surf B Biointerfaces. 2016;145:626–633.
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhu T, Yi C, et al. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake. Drug Dev Ind Pharm. 2016;42(5):701–706.
   PubMed Web of Science ®Google Scholar
• Luo Y, Teng Z, Li Y, et al. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Carbohydr Polym. 2015;122:221–229.
   PubMed Web of Science ®Google Scholar
• Rostamkalaei SS, Akbari J, Saeedi M, et al. Topical gel of Metformin solid lipid nanoparticles: a hopeful promise as a dermal delivery system. Colloids Surf B Biointerfaces. 2019;175:150–157.
   PubMed Web of Science ®Google Scholar
• Sharma M, Gupta N, Gupta S. Implications of designing clarithromycin loaded solid lipid nanoparticles on their pharmacokinetics, antibacterial activity and safety. RSC Adv. 2016;6(80):76621–76631.
   Web of Science ®Google Scholar
• Carter CB, Williams DB. Transmission electron microscopy: diffraction, imaging, and spectrometry. Cham: Springer, 2016.
   Google Scholar
• Kasongo KW, Pardeike J, Müller RH, et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. J Pharm Sci. 2011;100(12):5185–5196.
   PubMed Web of Science ®Google Scholar
• Kumar R, Singh A, Sharma K, et al. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles. Mater Sci Eng C Mater Biol Appl. 2020;106:110184.
   PubMed Web of Science ®Google Scholar
• Montoto SS, et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation. Colloids and Surfaces B: Biointerfaces. 2018;167:73–81.
   PubMed Web of Science ®Google Scholar
• Almeida LN, Araújo TG. Solid lipid nanoparticles: the efficiency carrier for topical delivery of hydrophilic drugs. WJPPS. 2017;6(9):175–189.
   Google Scholar
• Ghafary S, Ranjbar S, Larijani B, et al. Novel morpholine containing cinnamoyl amides as potent tyrosinase inhibitors. Int JBiolMacromol. 2019;135:978–985.
   PubMed Web of Science ®Google Scholar
• Dehghani Z, Khoshneviszadeh M, Khoshneviszadeh M, et al. Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers. Bioorg Med Chem. 2019;27(12):2644–2651.
   PubMed Web of Science ®Google Scholar
• Jiménez Z, Kim Y-J, Mathiyalagan R, et al. Assessment of radical scavenging, whitening and moisture retention activities of Panax ginseng berry mediated gold nanoparticles as safe and efficient novel cosmetic material. Artif Cells Nanomed Biotechnol. 2018;46(2):333–340.
   PubMed Web of Science ®Google Scholar
• Ashooriha M, Khoshneviszadeh M, Khoshneviszadeh M, et al. 1,2,3-Triazole-based kojic acid analogs as potent tyrosinase inhibitors: design, synthesis and biological evaluation. Bioorg Chem. 2019;82:414–422.
   PubMed Web of Science ®Google Scholar
• Beck R, Guterres S, Pohlmann A. Nanocosmetics and nanomedicines: new approaches for skin care. Berlin: Springer, 2011.
   Google Scholar
• Lin Y-K, Al-Suwayeh SA, Leu Y-L, et al. Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata. Pharm Res. 2013;30(2):435–446.
   PubMed Web of Science ®Google Scholar
• Kalhapure RS, Mocktar C, Sikwal DR, et al. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2014;117:303–311.
   PubMed Web of Science ®Google Scholar
• Kelidari HR, Saeedi M, Akbari J, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;128:473–479.
   PubMed Web of Science ®Google Scholar
• Yadav K, et al. Proniosomal gel: a provesicular approach for transdermal drug delivery. Der Pharmacia Lettre. 2010;2(4):189–198.
   Google Scholar
• Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed. 2007;2(3):289.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–177.
   PubMed Web of Science ®Google Scholar
• Shah R. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci. 2014;25(1):59–74.
   Google Scholar
• Bazzaz BSF, et al. Antibacterial efficacy of rifampin loaded solid lipid nanoparticles against Staphylococcus epidermidis biofilm. Microb Pathogenesis. 2016;93:137–144.
   PubMed Web of Science ®Google Scholar
• Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. Eur J Pharm Sci. 2012;47(1):139–151.
   PubMed Web of Science ®Google Scholar
• Bhalekar MR, Madgulkar AR, Desale PS, et al. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis. Drug Dev Ind Pharm. 2017;43(6):1003–1010.
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, et al. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization. Int J Pharm. 2007;340(1-2):153–162.
   PubMed Web of Science ®Google Scholar
• Jain A, Sharma G, Thakur K, et al. Beta-carotene-encapsulated solid lipid nanoparticles (BC-SLNs) as promising vehicle for cancer: an investigative assessment. AAPS PharmSciTech. 2019;20(3):100.
   PubMed Web of Science ®Google Scholar
• Shenoy VS, Rajyaguru TH, Gude RP, et al. Studies on paclitaxel-loaded glyceryl monostearate nanoparticles. J Microencapsul. 2009;26(6):471–478.
   PubMed Web of Science ®Google Scholar
• Kumar R, Yasir M, Saraf SA, et al. Glyceryl monostearate based nanoparticles of mefenamic acid: fabrication and in vitro characterization. Drug Invention Today. 2013;5(3):246–250.
   Google Scholar
• Butani D, Yewale C, Misra A. Topical Amphotericin B solid lipid nanoparticles: design and development. Colloids Surf B Biointerfaces. 2016;139:17–24.
   PubMed Web of Science ®Google Scholar
• Rompicharla SVK, Bhatt H, Shah A, et al. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity. Chem Phys Lipids. 2017;208:10–18.
   PubMed Web of Science ®Google Scholar
• Gardouh AR. Design and characterization of glyceryl monostearate solid lipid nanoparticles prepared by high shear homogenization. BJPR. 2013;3(3):326–346.
   Google Scholar
• Freitas C, Müller R. Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 1999;47(2):125–132.
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chandrasekar D, Ramakrishna S, et al. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1-2):167–175.
   PubMed Web of Science ®Google Scholar
• Pancholi K, Stride E, Edirisinghe M. In vitro method to characterize diffusion of dye from polymeric particles: a model for drug release. Langmuir. 2009;25(17):10007–10013.
   PubMed Web of Science ®Google Scholar
• Righeschi C, Bergonzi MC, Isacchi B, et al. Enhanced curcumin permeability by SLN formulation: the PAMPA approach. LWT-Food Science and Technology. 2016;66:475–483.
   Web of Science ®Google Scholar
• Reddy LH, Murthy R. Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech. 2005;6(2):E158–E166.
   PubMed Web of Science ®Google Scholar
• Baig MS, Ahad A, Aslam M, et al. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: optimization, in vitro release, ocular tolerance, and antibacterial activity . Int J Biol Macromol. 2016;85:258–270.
   PubMed Web of Science ®Google Scholar
• Attama AA, Umeyor CE. The use of solid lipid nanoparticles for sustained drug release. Ther Deliv. 2015;6(6):669–684.
   PubMed Web of Science ®Google Scholar
• Devi R, Jain A, Hurkat P, et al. Dual drug delivery using lactic acid conjugated SLN for effective management of neurocysticercosis. Pharm Res. 2015;32(10):3137–3148.
   PubMed Web of Science ®Google Scholar
• Pyo SM, Meinke M, Klein AF, et al. A novel concept for the treatment of couperosis based on nanocrystals in combination with solid lipid nanoparticles (SLN). Int J Pharm. 2016;510(1):9–16.
   PubMedGoogle Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Üner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die pharmazie Int J Pharm Sci. 2006;61(5):375–386.
   Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95(3):627–638.
   PubMed Web of Science ®Google Scholar
• Emami S, Hosseinimehr SJ, Shahrbandi K, et al. Synthesis and evaluation of 2(3H)-thiazole thiones as tyrosinase inhibitors. Arch Pharm (Weinheim). 2012;345(8):629–637.
   PubMed Web of Science ®Google Scholar
• Faig JJ, Moretti A, Joseph LB, et al. Biodegradable kojic acid-based polymers: controlled delivery of bioactives for melanogenesis inhibition. Biomacromolecules. 2017;18(2):363–373.
   PubMed Web of Science ®Google Scholar
• Shrotriya S, Ranpise N, Satpute P, et al. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Artif Cells Nanomed Biotechnol. 2018;46(7):1471–1482.
   PubMed Web of Science ®Google Scholar
• Byford T. Environmental health criteria 235: dermal absorption. Int J Environ Stud. 2009;66(5):662–663.
   Google Scholar
• Huong SP, Bun H, Fourneron J-D, et al. Use of various models for in vitro percutaneous absorption studies of ultraviolet filters. Skin Res Technol. 2009;15(3):253–261.
   PubMed Web of Science ®Google Scholar
• SCCS. Basic criteria for the in vitro assessment of dermal absorption of cosmetic ingredients. Brussels: European Commission Health & Consumers, 2010.
   Google Scholar
• Wang X-R, Gao S-Q, Niu X-Q, et al. Capsaicin-loaded nanolipoidal carriers for topical application: design, characterization, and in vitro/in vivo evaluation. Int J Nanomedicine. 2017;12:3881–3898.
   PubMed Web of Science ®Google Scholar
• van de Sandt JJ, Meuling WJ, Elliott GR, et al. Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur. Toxicol Sci. 2000;58(1):15–22.
   PubMed Web of Science ®Google Scholar
• Escribano E, Obach M, Arévalo MI, et al. Rapid human skin permeation and topical anaesthetic activity of a new amethocaine microemulsion. Skin Pharmacol Physiol. 2005;18(6):294–300.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–195.
   PubMed Web of Science ®Google Scholar
• Borgia SL, et al. Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release. 2005;110(1):151–163.
   PubMed Web of Science ®Google Scholar
• Garcês A, Amaral MH, Sousa Lobo JM, et al. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: a review. Eur J Pharm Sci. 2018;112:159–167.
   PubMed Web of Science ®Google Scholar
• Riddick T. Control of colloid stability. Zeta Potential. Staunton, VA: Zeta-Meter Inc, 2007. p. 198–200.
   Google Scholar